Wednesday, September 10, 2008

Still exploring Options

It looks like the trial for R1507 (the inhibitor we thought looked most promising) is closed to Synovial Sarcoma patients. Killian wants to get on something right away instead of waiting for this or that preferred trial. SO, we have until the end of this week to tell NIH whether we'll take them up on the Cediranib (VEGF - rz) trial. the VEGF-trap trial through NY Columbia Pres. is preferrable because it'd be back "home," and that hospital has so many other services we could all use - Integrative Therapies, family counseling, etc... But, as Killian wishes, we will go with whatever bird is in hand by Friday.

We suspect that lots of trials will keep coming up for R1507 if either VEGF inhibitor doesn't work. R1507 inhibits IGF reception. There might be some homeopathic drugs to help with this too.

Killian and I fly back to Cally and Phil this afternoon. We all need to be together for a little while.

No comments: